![]() Sunesis Pharmaceuticals Sunesis Pharmaceuticals is focused on the R&D of oncology therapeutics for the treatment of solid and hematologic cancers. | ![]() Omeros Omeros Corporation is a biopharmaceutical company developing products focused on inflammation and central nervous system disorders as well as immune-related diseases, including cancers. | ![]() Iovance Biotherapeutics Iovance Biotherapeutics (formerly Lion Biotechnologies) is focused on the development and commercialization of novel cancer immunotherapies based on tumor infiltrating lymphocytes. | ||
Founding Date | Founding Date 2002 | Founding Date 1987 | Founding Date 1994 | Founding Date 2013 |
Type | Type Subsidiary | Type Subsidiary | Type Public | Type Public |
Tags | ||||
Locations | Locations Hørsholm, DK HQ | Locations South San Francisco, US HQ | Locations Seattle, US HQ | Locations San Carlos, US HQ New York, US Philadelphia, US Philadelphia, US Tampa, US |
Employees | Employees 13 | Employees 42 | Employees 1968% decrease | Employees 14868% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 248.6 m | Valuation ($) 3.3 b |
Financial | ||||
Net income | Net income N/A | Net income ($114.8m) (FY, 2021) | Net income ($156.8m) (FY, 2024) | Net income ($372.2m) (FY, 2024) |
Funding | ||||
Total funding raised | Total funding raised $ 8m | Total funding raised $ 171.7m | Total funding raised $ 354.8m | Total funding raised $ 100m |
Sunesis Pharmaceuticals is focused on the R&D of oncology therapeutics for the treatment of solid and hematologic cancers.
View companyOmeros Corporation is a biopharmaceutical company developing products focused on inflammation and central nervous system disorders as well as immune-related diseases, including cancers.
View companyIovance Biotherapeutics (formerly Lion Biotechnologies) is focused on the development and commercialization of novel cancer immunotherapies based on tumor infiltrating lymphocytes.
View company